ERA Congress: Semaglutide linked to better quality of life in diabetes and kidney disease, FLOW trial shows

/CNW/ -- New findings from the landmark FLOW trial, presented at the 63rd ERA Congress, show that once-weekly semaglutide significantly improved health-related...